Kissei Pharmaceutical Co., Ltd. (4547) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Pharma Foods International Co., Ltd.

Kissei Pharmaceutical Co., Ltd.

CB GROUP MANAGEMENT Co., Ltd.

Astena Holdings Co., Ltd.

O'will Corp.

Morishita Jintan Co., Ltd.

Yomeishu Seizo Co., Ltd.

euglena Co., Ltd.

NANO MRNA Co., Ltd.

CellSeed, Inc.

Ohki Health Care Holdings, Inc.

Why is Kissei Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROE of 5.25%

The company has been able to generate a Return on Equity (avg) of 5.25% signifying low profitability per unit of shareholders funds

Weak Long Term Fundamental Strength with a -198.55% CAGR growth in Operating Profits over the last 5 years

The company has been able to generate a Return on Capital Employed (avg) of 1.34% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of 7.34% and Operating profit at -198.55% over the last 5 years

Flat results in Jun 26

INTEREST(HY) At JPY 16 MM has Grown at 33.33%

With ROE of 6.44%, it has a very attractive valuation with a 0.86 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -8.29%, its profits have fallen by -0.4% ; the PEG ratio of the company is 5.3
At the current price, the company has a high dividend yield of 0

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Kissei Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Kissei Pharmaceutical Co., Ltd. for you?

Low Risk, High Return

Absolute

Risk Adjusted

Volatility

Kissei Pharmaceutical Co., Ltd.

-8.29%

541.17

29.55%

Japan Nikkei 225

59.79%

2.03

29.50%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.34%

EBIT Growth (5y)

-198.55%

EBIT to Interest (avg)

55.25

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

0.40

Tax Ratio

17.35%

Dividend Payout Ratio

60.33%

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

1.17%

ROE (avg)

5.25%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.86

EV to EBIT

-65.13

EV to EBITDA

56.73

EV to Capital Employed

0.82

EV to Sales

1.47

PEG Ratio

5.28

Dividend Yield

ROCE (Latest)

-1.26%

ROE (Latest)

6.44%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

INVENTORY TURNOVER RATIO(HY)

Highest at 2.06 times

CASH AND EQV(HY)

Highest at JPY 107,378 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 3.59 times

PRE-TAX PROFIT(Q)

Highest at JPY 6,261 MM

NET PROFIT(Q)

Highest at JPY 4,698.78 MM

EPS(Q)

Highest at JPY 113.94

-8What is not working for the Company

INTEREST(HY)

At JPY 16 MM has Grown at 33.33%

Here's what is working for Kissei Pharmaceutical Co., Ltd.

Inventory Turnover Ratio

Highest at 2.06 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Pre-Tax Profit

Highest at JPY 6,261 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

Highest at JPY 4,698.78 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS

Highest at JPY 113.94

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Cash and Eqv

Highest at JPY 107,378 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio

Highest at 3.59 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Kissei Pharmaceutical Co., Ltd.

Interest

At JPY 16 MM has Grown at 33.33%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)